Reports world wide Duchenne Muscular Dystrophy (DMD) | Page 3

Figure 1: Trends in prevalent cases of Duchenne muscular dystrophy, 2016 – 25 Figure 2: Overview of pipeline drugs for Duchenne muscular dystrophy in the US Figure 3: Pipeline drugs for Duchenne muscular dystrophy, by company Figure 4: Pipeline drugs for Duchenne muscular dystrophy, by drug type Figure 5: Pipeline drugs for Duchenne muscular dystrophy, by classifications Figure 6: Key upcoming events in Duchenne muscular dystrophy Figure 7: Licensing and asset acquisition deals in disease name, 2012 – 17 Figure 8: Parent patents in Duchenne muscular dystrophy Figure 9: Clinical trials in Duchenne muscular dystrophy Figure 10: Top 10 drugs for clinical trials in Duchenne muscular dystrophy Figure 11: Top 10 companies for clinical trials in Duchenne muscular dystrophy Figure 12: Trial locations in Duchenne muscular dystrophy Figure 13: Duchenne muscular dystrophy trials status Figure 14: Duchenne muscular dystrophy trials sponsors, by phase
LIST OF TABLES
Table 1: Prevalent cases of Duchenne muscular dystrophy, 2016 – 25 Table 2: Marketed drugs for Duchenne muscular dystrophy Table 3: Approvals by country for Duchenne muscular dystrophy Table 4: Pipeline drugs for Duchenne muscular dystrophy in the US Table 5: Historical global sales, by drug($ m), 2012 – 16 Table 6: Forecasted global sales, by drug($ m), 2017 – 22
Ask to Expertise @ https:// www. reportsworldwide. com / enquiry? report _ id = 42606
About US:
Reportsworldwide. com is a one stop shop for all market intelligence needs. Our database of market research reports provides in depth coverage of 12 top industry verticals worldwide. We help you meet your market intelligence needs by mapping it with our database of market research reports including.
Contact Us:
Email: sales @ reportsworldwide. com
Phone: + 1( 617) 398-1947